Skip to content
Tenfell
Awarded contract
Published 24 Mar 2023

NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023

NHS England · London

Key facts

Awarded
03 Mar 2023
Contract starts
31 Mar 2023
Contract ends
28 Feb 2026
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 6 suppliers

SupplierValue
FRESENIUS KABI LIMITED—
Abbvie Ltd—
Amgen Ltd—
Sandoz Ltd—
Biogen—
Celltrion Healthcare United Kingdom Limited—

Description

Project Title: NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023

Offer reference number: CM/PHR/22/5660

CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab Injection to South of England. Period of framework: 1 April 2023 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab Injection to the Midlands and East. Period of framework: 1 April 2023 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab Injection to London. Period of framework: 1 April 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab Injection to the North of England. Period of framework: 1 April 2023 to 28 February 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.